Eur Rev Med Pharmacol Sci 2017; 21 (22): 5207-5210

DOI: 10.26355/eurrev_201711_13841

Review of recent advances in the management of hypertrophic cardiomyopathy

Y. Cao, P.-Y. Zhang

Department of Cardiology, Xuzhou Hospital of Traditional Chinese Medicine, Xuzhou, Jiangsu, China. caoyongtcm@163.com


Hypertrophic cardiomyopathy (HCM) is a complex but common monogenic cardiovascular disorder characterized by unexplained non dilated left ventricular (LV) thickening in the absence of another cardiac or systemic disease. The condition is associated with sudden and unexpected death in young individuals including trained athletes. HCM represents a genetic disorder caused by mutations in genes encoding sarcomeric proteins of the cardiac myocyte. This review article discusses the genetics behind HCM, its clinical presentation, and diagnosis and the present-day pharmacological management of HCM.

Free PDF Download

To cite this article

Y. Cao, P.-Y. Zhang
Review of recent advances in the management of hypertrophic cardiomyopathy

Eur Rev Med Pharmacol Sci
Year: 2017
Vol. 21 - N. 22
Pages: 5207-5210
DOI: 10.26355/eurrev_201711_13841